# A Study Comparing the Efficacy and Safety of Intracoronary Stenting With or Without Abciximab, an Anti-Platelet Therapy, and Conventional Coronary Angioplasty With Abciximab

> **NCT00271401** · PHASE3 · COMPLETED · sponsor: **Centocor, Inc.** · enrollment: 2399 (actual)

## Conditions studied

- Angioplasty, Transluminal, Percutaneous Coronary

## Interventions

- **OTHER:** Angioplasty
- **OTHER:** Intracoronary Stent
- **DRUG:** Abxicimab
- **DRUG:** Heparin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00271401
- **Lead sponsor:** Centocor, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-07
- **Primary completion:** 1997-09
- **Final completion:** 1997-09
- **Target enrollment:** 2399 (ACTUAL)
- **Last updated:** 2015-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00271401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00271401, "A Study Comparing the Efficacy and Safety of Intracoronary Stenting With or Without Abciximab, an Anti-Platelet Therapy, and Conventional Coronary Angioplasty With Abciximab". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00271401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*